ConductScience.org, home

Paper32542016

Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.

Nguyen TN and 2 others. PLoS One, 2020. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. Papers, record 32542016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32542016

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
PubMed
Journal
PLoS One
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2020-08-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nguyen TNTran Nhttps://orcid.org/0000-0003-2017-1694
2Nguyen HQHa Q
3Le DHDuc-Hau

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Gene Expression ProfilingMajor topic
Liver NeoplasmsMajor topic
TyrosineMajor topic
Cell Line, Tumor
Down-Regulation
Humans
MicroRNAs
Mutation
Prognosis

Source PubMed

Download CSV of topics

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126258887PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.Nat Commun2015https://conductscience.org/library/papers/26258887PubMed
22378357Visceral pathology of hereditary tyrosinemia type I.Am J Hum Genet1990https://conductscience.org/library/papers/2378357PubMed
330560924Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.Cell Res2019https://conductscience.org/library/papers/30560924PubMed
425516281Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol2014https://conductscience.org/library/papers/25516281PubMed
56090002Serum amino acid levels in patients with hepatocellular carcinoma.Cancer1984https://conductscience.org/library/papers/6090002PubMed
620370557Reactive oxygen species in cancer.Free Radic Res2010https://conductscience.org/library/papers/20370557PubMed
721147110Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.Gastroenterology2011https://conductscience.org/library/papers/21147110PubMed
829366974Obesity linking to hepatocellular carcinoma: A global view.Biochim Biophys Acta Rev Cancer2018https://conductscience.org/library/papers/29366974PubMed
921279699Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.Med Oncol2012https://conductscience.org/library/papers/21279699PubMed
107972132Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7972132PubMed
1125613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
1229386513Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.Nat Commun2018https://conductscience.org/library/papers/29386513PubMed
1328393215miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.Oncol Rep2017https://conductscience.org/library/papers/28393215PubMed
1427717846microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.Life Sci2016https://conductscience.org/library/papers/27717846PubMed
1528407145GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.Nucleic Acids Res2017https://conductscience.org/library/papers/28407145PubMed
1630013665MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.Oncol Lett2018https://conductscience.org/library/papers/30013665PubMed
1729413959Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.Redox Biol2018https://conductscience.org/library/papers/29413959PubMed
1821527027GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.Genome Biol2011https://conductscience.org/library/papers/21527027PubMed
1928622513Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.Cell2017https://conductscience.org/library/papers/28622513PubMed
2015894488Plasma free amino acid profile in cancer patients.Semin Cancer Biol2005https://conductscience.org/library/papers/15894488PubMed

See all 65 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42038754A Systematic Bioinformatic Analysis of the miRNA Pathway in Inborn Errors of Amino Acid Metabolism Disorders.Mol Syndromol2026https://conductscience.org/library/papers/42038754PubMed
41840833Association between urinary polycyclic aromatic hydrocarbon metabolites and sleep disturbances: A cross-sectional study integrating machine learning and network toxicology.J Int Med Res2026https://conductscience.org/library/papers/41840833PubMed
41501789Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming.Mol Cancer2026https://conductscience.org/library/papers/41501789PubMed
41006587Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling.Sci Rep2025https://conductscience.org/library/papers/41006587PubMed
39592837Metabolomics analysis reveals resembling metabolites between humanized γδ TCR mice and human plasma.Sci Rep2024https://conductscience.org/library/papers/39592837PubMed
39415432Associations between prediagnostic plasma metabolites and biliary tract cancer risk in the prospective UK Biobank cohort.Am J Epidemiol2025https://conductscience.org/library/papers/39415432PubMed
39025801Structural and Evolutionary Relationships of Melanin Cascade Proteins in Cnidarian Innate Immunity.Integr Comp Biol2024https://conductscience.org/library/papers/39025801PubMed
38822068Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanoma.Sci Rep2024https://conductscience.org/library/papers/38822068PubMed
38415454Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.Curr Med Chem2025https://conductscience.org/library/papers/38415454PubMed
38248831The Role of Amino Acids in Non-Enzymatic Antioxidant Mechanisms in Cancer: A Review.Metabolites2023https://conductscience.org/library/papers/38248831PubMed
38248814Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics.Metabolites2023https://conductscience.org/library/papers/38248814PubMed
38169417Changes in the composition of the fecal metabolome and gut microbiota contribute to intervertebral disk degeneration in a rabbit model.J Orthop Surg Res2024https://conductscience.org/library/papers/38169417PubMed
37906252Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.JCI Insight2023https://conductscience.org/library/papers/37906252PubMed
37407700TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma.Sci Rep2023https://conductscience.org/library/papers/37407700PubMed
36797544Function of TRPC1 in modulating hepatocellular carcinoma progression.Med Oncol2023https://conductscience.org/library/papers/36797544PubMed
36555470Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis.Int J Mol Sci2022https://conductscience.org/library/papers/36555470PubMed
36341373Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.Front Immunol2022https://conductscience.org/library/papers/36341373PubMed
36140419Transcriptomic Harmonization as the Way for Suppressing Cross-Platform Bias and Batch Effect.Biomedicines2022https://conductscience.org/library/papers/36140419PubMed
35847355Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer.J Oncol2022https://conductscience.org/library/papers/35847355PubMed
35790430[Exploration of the therapeutic mechanism of Yiqi Jiedu recipe for treatment of primary liver cancer based on network pharmacology and molecular docking].Nan Fang Yi Ke Da Xue Xue Bao2022https://conductscience.org/library/papers/35790430PubMed

See all 28 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32542016

GET https://conductscience.org/api/papers/v1/32542016/references?page=2